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Study investigated the effect of oral administration of gold-silver nanoparticles
on rat biochemical parameters and tissue morphology. Wistar rats weighing
approximately 180±7 g were randomly assigned into four groups. Animals in the
control group received distilled water once daily for 30 days while, those in the
treatment groups were administered  10,  50  and  100  mg  kgG1 b.wt. gold-silver
nanoparticles. The rats were sacrificed under slight anesthesia, 24 h after the last
treatments. Blood and vital organs including the heart, kidney and liver were
collected and prepared for biochemical and histopathological determinations.
Exposure to Ag/Au nanoparticles altered the rat serum lipid profile; lowering the
HDL-C while raising the atherogenic index. Exposure of Ag/Au nanoparticles in
rats caused significant alteration to the levels of serum albumin, total protein,
bilirubin, urea and creatinine. The activities of alanine transaminase, aspartate
transaminase and alkaline phosphatase in rat serum and tissues were also
significantly altered by Ag/Au nanoparticles exposure. The histopathological
examination revealed inflammation and cellular degeneration caused by exposure
to the Ag/Au nanoparticles. We show evidence that Ag/Au nanoparticles elevated
atherogenic index, as well as caused biochemical and morphological alterations,
reminiscent of cellular injury.
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INTRODUCTION
Metal nanoparticles, especially silver and gold, have
been  implicated  for several bioactivities (Lee et al.,
2002; Saha et al., 2008; Barathmanikanth et  al., 2010;
Salma et al., 2011). The antimicrobial property of silver
nanoparticles has led to their wide-spread use in bedding,
water purification, tooth paste, shampoo, rinse, infant
nipples nursing bottles, fabrics, deodorants, filters, kitchen
utensils, toys and humidifiers (Maynard et al., 2006).
Gold nanoparticles are compatible for a wide range of
biological applications, because of their unique physical
and chemical properties. Recently, the applications of
gold nanoparticles have expanded into various biomedical
fields (biosensors, immunoassays, genomics, photo
thermolysis of cancer cells, microorganisms detection and
control, targeted drug delivery, optical imaging,
monitoring of biological cells and tissues by exploiting
resonance scattering, or in vivo photo acoustic techniques
(Gupta et al., 2007; Adeyemi and Sulaiman, 2015).
Despite the wide application of nanoparticles, there is a
serious lack of information concerning their impact on
human health and the environment. Very little is known
about the toxicity of nano-sized particles, however, the
size and surface area are recognized as important
determinants for toxicity (Ji et al., 2007). The increasing
usage of these nanoparticles and nanomaterials,
underscores research efforts to identify probable or likely
toxic events that may ensue following exposure.
The present study evaluated the effect of the oral
exposure of Ag/Au nanoparticles on biochemical indices
and tissue morphology in rats.
MATERIALS AND METHODS
Nanoparticles: The silver/gold nanoparticles (Ag/Au
nanoparticles) were from the Nanomedicine and
Biomedical Target Laboratory, Department of
Biochemistry, Microbiology and Biotechnology, Rhodes
University, South Africa. The preparation procedures and
characterization  have  been previously reported (Adeyemi
and Whiteley, 2013, 2014). The dark brown Ag/Au 
nanoparticles  absorbed  maximally at 420 and 550 nm for
Ag and Au respectively. The diameter size of the
nanoparticles ranges between 10-40 nm.
Experimental animals: Male Wistar rats of average
weight of 180+7 g were obtained from the animal unit of
the Department of Biochemistry, University of Ilorin,
Nigeria.
Chemicals and reagents: The assay kits for Total
Cholesterol (TC), triacylglycerol (TAG), High Density
Lipoprotein (HDL-C), Free Glycerol (FG), creatinine
(CREA), urea, bilirubin (BIL), albumin (ALB), alkaline
phosphatase (ALP), alanine aminotransferase (ALT) and
aspartate aminotransferase (AST) were products of
Randox Laboratory Limited, Atrim, United Kingdom. All
other reagents and chemicals used were of analytical
grade and supplied by Sigma Aldrich Inc., St. Louis,
USA.
Animal groupings and treatments: The animals were
kept in plastic cages contained in the experimental animal
house and allowed to acclimatize for two weeks before
commencement of treatments. Animals were maintained
under standard hygienic conditions with alternate 12 h
light and dark cycle. Animals were given free access to
rat chow and clean water ad libitum. Handling of animals
was consistent with relevant guidelines on the care and
use of laboratory animals (National Research Council,
2011). The details of animal groupings are as shown
below:
Group 1: Served as the Control and received 0.5 mL of
distilled water
Group 2: Received 0.5 mL of 10 mg kgG1 b.wt. of
Ag/Au nanoparticles
Group 3: Received 0.5 mL of 50 mg kgG1 b.wt. of
Ag/Au nanoparticles
Group 4: Received 0.5 mL of 100 mg kgG1 b.wt. of
Ag/Au nanoparticles
The treatments were orally administered by means of
a gavage. Treatments were daily and lasted for 30 days.
Preparation of serum and tissue homogenates: The
animals were sacrificed under ethyl ether anesthesia 24 h
after cessation of treatments. The blood was collected into
a clean and sterile sample bottles. The blood was
centrifuged at 3000 g for 10 min using a Uniscope
Laboratory Centrifuge (Model SM800B) to yield the
serum, which was stored frozen until required for
analyses. The vital organs including the liver, kidney and
heart were removed, blotted, weighed   and homogenized
in ice-cold 0.25 M sucrose solution (1:5 w/v). The
homogenates were kept frozen until used for the
biochemical analyses. Part of each excised tissue was
fixed in 10% Buffered Neutral Formalin (BNF) and used
for the histopathological examination.
Determination of biochemical parameters: All
biochemical measurements were done  using Spectronic
21 spectrophotometer (Bausch and Lomb, NY). The
activities of aspartate transaminase (AST) (E.C. 2.6.1.1),
alanine transaminase (ALT) (E.C. 2.6.1.2), alkaline
phosphatase (ALP) (E.C.3.1.3.1), albumin (ALB),
bilirubin  (BIL),  creatinine,  urea,  serum total cholesterol
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concentration (TC), High Density Lipoprotein Cholesterol
(HDL-C) and triacylglycerol (TAG) was assayed using
the Randox assay kits (Crumlin, UK). The concentration
of serum Low Density Lipoprotein (LDL-C) was
estimated using Friedewald formula (Warnick et al.,
1990) while, the Atherogenic Index (AI) was estimated by
finding the ratio of the TC to HDL-C concentration. The
protein content of the serum and homogenates was
determined using the Biuret method as previously
described by Sulaiman and Adeyemi (2010).
Histological examination: The preparation of tissue
sections for histological examination under light
microscope followed the standard embedding and H-E
staining protocol. The photomicrographs were  captured
at 100X using the software, Presto! Image Folio package.
Statistical analysis: Data was analyzed using the analysis
of variance (ANOVA) and Duncan multiple range test on
SPSS package. The data were presented as
Mean±Standard error of mean. Group mean value at 5%
level of confidence (p<0.05) was considered significant.
RESULTS
Average weight of animals: Figure 1 shows the average
rat weight after exposure to silver/gold nanoparticles. At
the highest dosage, the nanoparticles caused reduction
(p<0.05) in rat weights relative to control. The rat organ
weights were also decreased by nanoparticle treatment
when compared to the control (Table 1). In like manner,
the percentage liver and kidney-to-body weight ratio of
rats administered with Ag/Au nanoparticle for 30 days
decreased relative to the control (Table 2).
Lipid profile: The nanoparticles altered the rat lipid
profile following daily exposure for  30  days (Table 3
and 4). The estimation of LDL in rat serum following
daily exposure to Ag/Au nanoparticle reveals significant
elevation at the dose of 10 mg kgG1 b.wt. compared with
the control. The atherogenic index was also estimated for
rats after exposure to Ag/Au nanoparticles for 30 days.
Data show elevation in atherogenic index caused by
Ag/Au nanoparticles at the highest dose.
Total protein: The rat  serum  total  protein concentration
was   reduced    following    daily     exposure    to  Ag/Au
nanoparticles. In contrast, levels of total protein rat heart, 
liver and kidney tissues were significantly elevated
relative to the control (Table 5). 
Table 1: Weight of rat organs following oral exposure to silver/gold
nanoparticles
Organs weight of rats (g)
-----------------------------------------------------
Groups Heart Liver Kidney
Control 1.40±0.00 8.13±0.09 2.10±0.12
Ag/Au 10 (mg kgG1) 1.43±0.03 7.60±0.58* 1.90±0.10*
Ag/Au 50 (mg kgG1) 1.33±0.12 7.73±0.58* 1.90±0.10*
Ag/Au 100 (mg kgG1) 1.40±0.00 7.47±0.32* 1.83±0.15*
Values are expressed as Mean±SEM (n = 3), *Significant relative to
control at p<0.05, Ag/Au: Silver/gold
Table 2: Organ-to-body weight ratios of rat orally administered with
silver/gold nanoparticles
Percentage organ/body weight ratios (g)
-------------------------------------------------------
Groups Heart Liver Kidney
Control 0.82±0.04 4.76±0.26 1.23±0.12
Ag/Au 10 (mg kgG1) 0.77±0.06 4.10±0.45* 1.02±0.05*
Ag/Au 50 (mg kgG1) 0.78±0.08 4.58±0.55* 1.12±0.14*
Ag/Au 100 (mg kgG1) 0.87±0.04* 4.66±0.09* 1.13±0.03*
Values are expressed as Mean±SEM (n = 3), *Significant relative to
control at p<0.05, Ag/Au: Silver/gold
Fig. 1: Average weight of rat following oral exposure to silver/gold nanoparticles at different dosages. Data is expressed
as Mean±SEM (n = 3). α is significant at p<0.05 relative to the control
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Serum metabolites: For the evaluation of Ag/Au
nanoparticles   on   the  renal  and  liver  function  indices,
Table 3: Effect of silver/gold nanoparticles on the level of rat serum
total cholesterol, triacylglyceride and free glycerol
Total cholesterol Triacylglyceride Glycerol
Groups (mmol LG1) (mmol LG1) (mmol LG1)
Control  0.26±0.05  0.41±0.30  0.30±0.30
Ag/Au 10 (mg kg!1) 0.30±0.00* 0.82±0.59* 0.91±0.37*
Ag/Au 50 (mg kg!1) 0.19±0.05* 0.31±0.20* 0.20±0.20*
Ag/Au 100 (mg kg!1) 0.58±0.11* 0.30±0.04* 0.19±0.04*
Values are expressed as Mean±SEM (n = 3), *Significant relative to
control at p<0.05, Ag/Au: Silver/gold
Table 4: Effect of silver/gold nanoparticles on the level of rat serum
high density lipoprotein, low density lipoprotein and
atherogenic index
HDL-C LDL-C Atherogenic
Groups (mmol LG1) (mmol LG1) index 
Control 0.50±0.71 0.08±0.03 1.12±0.18
Ag 10 (mg kg!1) 0.46±0.01 0.20±0.04* 0.34±0.01*
Ag 50 (mg kg!1) 0.62±0.11* 0.07±0.02 0.47±0.05*
Ag 100 (mg kg!1) 0.24±0.05* 0.06±0.00 5.52±0.09*
Values are expressed as Mean±SEM (n = 3), *Significant relative to
control at p<0.05, Ag/Au: Silver/gold, HDL: High density lipoprotein,
LDL: Low density lipoprotein
serum urea, creatinine, albumin and bilirubin
concentrations were determined. The rat serum total
bilirubin level was raised (p<0.05), consequent upon the
administration of Ag/Au nanoparticles (Table 6). In
contrast, the levels of rat serum urea, albumin and
creatinine were significantly reduced by exposure to
Ag/Au nanoparticles relative to the control.
Other biochemical  indices:  In  order  to further
evaluate the effect of the administration of Ag/Au
nanoparticle on vital organ functions, activities of AST,
ALT and ALP were  determined  in  rat  serum and
tissues. Ag/Au nanoparticle exposure in rats led to
significant decreases in the activities of serum and tissue
AST, when compared with the control (Table 7). The
effect on the activities of  ALT  and  ALP  are as
presented in Table 8 and 9.
Histopathological examination: Histological
examination of rat heart following Ag/Au nanoparticle
administration revealed mild degeneration of cardiac
tissue  and   inflammation   (Fig.   2).  The  control  group 
Fig. 2(a-d): Photomicrographs of rat heart following sub-chronic exposure to silver/gold nanoparticles at different
dosages, (a) Control group given distilled water showing intact cellular morphology, (b) Group given
silver/gold nanoparticles at 10 mg kgG1, (c) Group given silver/gold nanoparticles at 50 mg kgG1 and (d)
Group given silver/gold nanoparticles at 100 mg kgG1 body weight showing inflammation and cellular
degeneration. H and E staining (×400)
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Table 5: Effect of silver/gold nanoparticles on the level of rat serum and tissue total protein
Total protein concentration (g dLG1)
---------------------------------------------------------------------------------------------------------------------------------
Group Serum Heart Kidney Liver
Control 2.52±0.51 3.75±1.47 6.65±1.94 7.72±2.34
Ag/Au 10 (mg kg!1) 2.84±0.30 12.81±4.46* 3.03±1.13* 9.88±4.92
Ag/Au 50 (mg kg!1) 2.01±1.65* 7.82±5.04* 10.95±3.50 15.85±8.78*
Ag/Au 100 (mg kg!1) 2.35±0.97* 9.37±0.66* 9.95±3.90 8.54±4.90
Values are expressed as Mean±SEM (n = 3), *Significant relative to control at p<0.05, Ag/Au: Silver/gold
Table 6: Effect of silver/gold nanoparticles on the level of rat serum metabolites
Groups Albumin (g dLG1) Bilirubin (mmol LG1) Creatinine (µmol LG1) Urea (mmol LG1)
Control 2.21±0.25 2.59±0.32 17.85±1.71 41.44±0.00
Ag/Au 10 (mg kg!1) 1.57±0.13* 19.79±0.00* 15.95±1.06* 35.78±4.57*
Ag/Au 50 (mg kg!1) 0.21±0.04* 12.95±1.06* 15.21±0.37* 22.48±7.50*
Ag/Au 100 (mg kg!1) 1.93±0.17* 8.94±0.163* 17.48±1.43* 30.85±4.57*
Values are expressed as Mean±SEM (n = 3), *Significant relative to control at p<0.05, Ag/Au: Silver/gold
Table 7: Effect of silver/gold nanoparticles on the activity of rat serum and tissue aspartate transaminase
AST (U LG1)
--------------------------------------------------------------------------------------------------------------------------------
Groups Serum Liver Kidney Heart
Control 51.67±5.78 57.17±4.44 54.67±3.24 51.83±9.49
Ag/Au 10 (mg kg!1) 34.83±23.35* 18.17±8.57* 16.33±2.83* 20.50±10.26*
Ag/Au 50 (mg kg!1) 23.83±7.78* 31.67±7.10* 20.00±4.62* 23.00±9.88*
Ag/Au 100 (mg kg!1) 29.67±3.94* 33.17±7.16* 23.83±5.17* 31.83±4.15*
Values are expressed as Mean±SEM (n = 3). * Significant relative to control at p<0.05, Ag/Au: Silver/gold, AST: Aspartate amino transferase
Table 8: Effect of silver/gold nanoparticles administration on the activity of rat serum and tissue alanine transaminase
ALT (U LG1)
----------------------------------------------------------------------------------------------------------------------------------
Groups Serum Liver Kidney Heart
Control 53.0±2.52 26.7±1.20 87.3±3.84 17.7±1.45
Ag/Au 10 (mg kg!1) 70.7±5.78* 41.0±1.53* 79.7±3.53* 74.7±10.5*
Ag/Au 50 (mg kg!1) 61.7±5.49* 75.3±5.33* 63.0±4.73* 68.0±3.61*
Ag/Au 100 (mg kg!1) 36.300±0.88* 38.300±3.33* 51.700±4.05* 47.000±3.00*
Values are expressed as Mean±SEM (n = 3). *Significant relative to control at p<0.05, Ag/Au: Silver/gold, ALT: Alanine amino transaminase
Table 9: Effect of silver/gold nanoparticles on the activity of rat serum and tissue alkaline phosphatase
ALP (U LG1)
-------------------------------------------------------------------------------------------------------------------------------
Groups Serum Liver Kidney Heart
Control 463.96±74.21 427.05±69.74 491.28±26.61 177.50±38.95
Ag/Au 10 (mg kg!1) 182.80±12.43* 156.27±1.50* 175.78±21.09* 159.07±32.90*
Ag/Au 50 (mg kg!1) 127.24±16.17* 182.02±37.69* 92.50±27.22* 274.77±78.18*
Ag/Au 100 (mg kg!1) 174.37±21.88* 168.80±23.64* 220.49±41.80* 191.82±23.11*
Values are expressed as Mean±SEM (n = 3), *Significant relative to control at p<0.05, Ag/Au: Silver/gold, ALP: Alkaline phosphatase
showed no incidence of cellular alteration in the cardiac
tissue. The examination of rat renal sections for
morphological changes revealed mild inflammation
caused by the administration  of  Ag/Au  nanoparticle
(Fig. 3). The control group showed intact cellular
architecture. Furthermore, exposure to Ag/Au
nanoparticle caused cellular lesion in rat hepatic tissue.
The cellular alteration caused by the nanoparticle
administration includes inflammation and cellular 
cracking (Fig. 4). The control group showed no visible
alteration to cellular architecture of the hepatic tissue.
DISCUSSION
The increasing usage of nanoparticles especially Ag
and Au nanoparticles for biomedical purposes necessitates
the safety evaluation of these nanoparticles. Recent
findings have shown that nanoparticles, because of their
small sizes, behave differently from the parent material
and have potential to predispose to oxidative cellular
damage (Hudecova et al., 2012; Adeyemi and Faniyan,
2014).
The daily administration of Ag/Au nanoparticles at
the highest dose (100 mg kgG1) to rats for 30 days caused
significant reductions to the average weights relative to
the control. This may be an early symptom of ensuing
toxic events caused by the nanoparticle exposure.
Previous studies have associated changes to body weight
with toxicity of drugs or chemicals (Orisakwe et al., 2004;
Adeyemi and Sulaiman, 2014).
In the present study, exposure of rats to Ag/Au
nanoparticles caused inconsistent alterations to the levels
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of TC, TAG, FG as well as HDL-C. The imbalances in
the lipid profile status of cells could predispose to several
health consequences. When the level of TC, TAG and
LDL are high, it could raise the risk of cardiovascular
disorder. A reduction in the HDL-C could be hazardous.
The HDLs may actually serve to retard or reduce
atherosclerotic buildup (Olukanni et al., 2013). The
administration of nanoparticles decreased the HDL-C in
the serum at the highest dose. This may increase the risk
of cardiovascular diseases. More so, the AI was elevated
by nanoparticle administration at the highest dose. The
rise in the atherogenic index may predispose to the
development of atherosclerosis (Adeyemi and Akanji,
2011a; Olukanni et al., 2013).
Total protein is composed of albumin and globulin
and reflects the balance of protein biosynthesis and
catabolism. The significant decrease in total protein at the
dose of 100 mg kgG1 might be due to decreased synthesis,
increased loss, increased catabolism, malabsorption or
liver disease consequent upon the administration of the
nanoparticles (Guyton and Hall, 2000). The level of serum
albumin could be used to evaluate the synthetic function
of the liver.  Decrease  in  albumin  has  been  observed in
serum of patients with tissue inflammation and damages
(Gabay and Kushner, 1999), which suggest that the
tissues of the experimental rats might have been injured
following administration of the nanoparticles.
The level of rat serum bilirubin increased following
the administration of Ag/Au nanoparticles. Previous study
has attributed demonstrated that increased red blood cell
hemolysis could cause elevated bilirubin beyond the
hepatic function capacity (Adeyemi et al., 2012).
Furthermore, to evaluate effect of the nanoparticle
exposure on kidney function, the serum urea and
creatinine levels were determined. Serum urea and
creatinine are useful indices for evaluating the status of
renal functions (Gross et al., 2005). A rise in the level of
serum  urea  may  imply  impaired renal excretion
(Adeyemi and Akanji, 2012). However, in the present
study, serum urea decreased. The decrease in the
concentration of serum urea after the administration of the
nanoparticles might be attributable to decreased amino
acid degradation by the liver. This is more plausible
considering the fact that the nanoparticle exposure also
caused decreased level of rat serum albumin. The level of
serum albumin  has  been  associated   with   the  synthetic
Fig. 3(a-d): Photomicrographs of rat kidney following sub-chronic exposure to silver/gold nanoparticles at different
dosages, (a) Control group given distilled water showing intact cellular morphology, (b) Group given
silver/gold nanoparticles at 10 mg kgG1 body weight showing mild inflammation, (c) Group given silver/gold
nanoparticles at 50 mg kgG1 body weight  and (d) Group given silver/gold nanoparticles at 100 mg kgG1 body
weight showing inflammation and cellular degeneration. H and E staining (×400)
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Fig. 4(a-d): Photomicrographs of rat liver following sub-chronic exposure to silver/gold nanoparticles at different
dosages, (a) Control group given distilled water showing intact cellular morphology, (b) Group given
silver/gold nanoparticles at 10 mg kgG1 body, (c) Group given silver/gold nanoparticles at 50 mg kgG1  and
(d) Group given silver/gold nanoparticles at 100 mg kgG1 body weight showing inflammation and cellular
degeneration. H and E staining (×400)
function of the liver (Adeyemi et al., 2010, 2012). In the
present study, the level of rat serum creatinine was
reduced significantly and may suggest enhanced
glomerular clearance or impaired muscle metabolism.
The measurement of the activity of some enzymes
could be used to evaluate for cellular toxicity arising from
exposure to chemical compounds including drugs
(Adeyemi and Akanji, 2011b). The alanine and aspartate
aminotransferases (ALT and AST) are ‘markers’ of liver
damage and can thus be used to assess liver cytolysis
(Adeyemi and Sulaiman, 2014; Sulaiman and Ekanem,
2009). The administration of Ag/Au nanoparticles
decreased the activities of AST and ALT in rat serum,
liver, kidney and heart relative to the control. This may be
due to inactivation of the enzyme molecules by the
nanoparticles or their metabolites. Recent findings have
demonstrated the potential of Ag or Au nanoparticles to
alter protein structure by forming a complex with the thiol
(-SH) group within the protein molecule (Adeyemi and
Whiteley, 2013, 2014). The Ag or Au nanoparticles have
affinity for -SH groups and as such could interfere with
the functional state of a protein molecule by binding to the
thiol groups. On the other hand, the activity of rat ALT
increased in the serum, liver and heart. The elevation of
ALT level in rat serum and tissues may be the result of
adaptive mechanism by the animals in order to offset the
stress imposed by the nanoparticle administration. Living
cells have been reported to increase the de novo synthesis
of proteins in response to stressors such as drugs or
chemical agents (Adeyemi and Sulaiman, 2012). The
elevation of ALT activity may also be an early indicator
for hepatotoxicity consequent upon exposure to
nanoparticles. Elevated level of serum ALT has been
linked with hepatic injury (Adeyemi and Akanji, 2012;
Sulaiman et al., 2014). A previous report has revealed that
metal nanoparticles altered the biochemical parameters
causing cellular damage (Kim et al., 2009). The present
findings on ALT and AST activities following exposure
to nanoparticles are consistent with an earlier report
(Salma et al., 2011), which demonstrated that metal
nanoparticles have potential to alter the activity of
transaminases.
Histological examination of tissue sections could
serve   as   complementary  evidence   to  the  biochemical
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evaluation. The incidence of inflammation, cellular
degeneration and hyperchromic anemia, which
characterized the nanoparticle-treated tissues may suggest
likely cellular toxicity. The cellular lesions caused by the
nanoparticle administration were absent in the control
group. The morphological alterations are evidence that
support  further  the  potential of the nanoparticles to
cause cellular damage. Earlier report by
Maneewattanapinyo et al. (2011) showed the LD50 of Ag
nanoparticles to be >5000 mg kgG1, however, the present
data suggest caution in exposure, essentially because a
separate study has demonstrated that nanoparticles could
sequester and bio-accumulate in tissues (Yang et al.,
2008).
There is increasing usage of nanoparticles for
biomedical purposes. However, our knowledge and
understanding of the effect of these nanoparticles on
living cells or biochemical indices remain insufficient
(Adeyemi et al., 2014). It has therefore, become
imperative that studies which aim to determine the
biochemical evaluations of nanoparticles, be encouraged.
To our knowledge, this is the first report showing
evidence that nanoparticles altered lipid profile and
elevated the atherogenic index.
CONCLUSION
The present data reveal the status of some cellular
biochemistry and morphological indices in the presence of
Ag/Au nanoparticles and would contribute to aid our
understanding of the potential effect of the exposure of
nanoparticles on cellular system.
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